TerminatedNCT03172533

Estrogen Replacement in Eating disorders

Medication studyAges 18–45Germany

The study in practice

Understand this study

Listed age limits: 18 years to 45 years.

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Study start dateStarted: March 15, 2016

Recruitment status: Terminated
Enrollment listed in the registry: 11
Sponsor: University of Erlangen-Nürnberg Medical School
Sponsor type: University
Study type: Drug
Intervention type: Drug
Study phase: Phase 2
Locations: Germany
Age range: From 18 Years to 45 Years
Official registry ID: NCT03172533
Official title: Show the full official title
Prospective, Randomized, Double-blind, Placebo-controlled Clinical Trial on the Effects of an Estrogen-progestin Combination as add-on to Inpatient Psychotherapy in Adult Female Patients Suffering From Anorexia Nervosa

Terminated

Erlangen

FAQ

Who is behind this study?

The study sponsor is University of Erlangen-Nürnberg Medical School, a university.

Does this study involve medication?

Yes. The study involves medication, including ethinyl estradiol 0.03mg and dienogest 2 mg (combination) and Placebo oral capsule.

Who can participate?

Listed age limits: 18 years to 45 years.

Is this study still recruiting?

The registry lists this study as terminated.